Wellgistics Health, Inc. (WGRX)
NASDAQ: WGRX · Real-Time Price · USD
4.365
+0.545 (14.27%)
Mar 31, 2025, 3:31 PM EDT - Market open

Company Description

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products.

It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.

It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty.

The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024.

Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Wellgistics Health, Inc.
Wellgistics Health logo
Country United States
Founded 2022
IPO Date Feb 21, 2025
Industry Medical Distribution
Sector Healthcare
Employees 31
CEO Brian Norton

Contact Details

Address:
3000 Bayport Drive, Suite 950
Tampa, Florida 33607
United States
Phone (844) 203-6092
Website wellgisticshealth.com

Stock Details

Ticker Symbol WGRX
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.50
CIK Code 0002030763
ISIN Number US9495031067
Employer ID 93-3264234
SIC Code 5122

Key Executives

Name Position
Tim Canning Chief Executive Officer
Vishnu Balu Chief Financial Officer
Chuck Wilson Chief Operating Officer
Dr. Shafaat Pirani Chief Clinical Officer and Executive Vice President Healthcare Operations
Brian Norton Chief Commercial Officer
Prashant Patel Chief Strategy Officer and Vice Chairman of the Board
Suren Ajjarapu Chairman of the Board
Sajid Syed Director
Donald W. Anderson Director
Rebecca Shanahan Director

Latest SEC Filings

Date Type Title
Mar 27, 2025 8-K Current Report
Mar 25, 2025 10-K Annual Report
Mar 21, 2025 8-K Current Report
Mar 6, 2025 424B3 Prospectus
Mar 6, 2025 8-K Current Report
Feb 28, 2025 8-K Current Report
Feb 26, 2025 8-K Current Report
Feb 21, 2025 424B4 Prospectus
Feb 20, 2025 CERT Certification by an exchange approving securities for listing
Feb 18, 2025 8-A12B Registration of securities